Irritable Bowel Syndrome with Diarrhea (IBS-D) Study
The BHT-II-002 Study is evaluating the effectiveness of an investigational medication for people with IBS.
We are looking for men and women who:*
- Are aged 18–70 years
- Have a diagnosis of IBS
During the study you will be asked to complete questionnaires and a daily diary of your medication intake using a smartphone provided.
Contacting us does not mean that you must join the study. If you are able to take part, your participation is entirely voluntary. The study will be discussed in detail with you by the study team. If you decide to join the study and meet all criteria, you will be asked to sign a consent form. However, you can withdraw from the study at any time, if you change your mind. There will be no charge for any study-related treatment or care and all reasonable travel costs will be reimbursed.
If you are interested in participating in our IBS-D study, please fill out the form below or call us at (423) 698-4584.